Immunogenicity and Safety of Menactra® Vaccine in Adolescents in Saudi Arabia

Mise à jour : Il y a 4 ans
Référence : NCT00444951

Femme et Homme

Extrait

This study will be conducted among adolescents in Saudi Arabia who previously received one dose of A, C, Y, W 135 and at least one dose of A, C meningococcal polysaccharide vaccine. This study will evaluate the booster administration of Menactra® (Meningococcal A, C, Y, and W 135 Polysaccharide Diphtheria Toxoid Conjugate vaccine) compared with Mencevax® (Meningococcal A, C, Y, and W 135 Polysaccharide vaccine)in terms of their serum bactericidal antibody responses.


Critère d'inclusion

  • Neisseria Meningitidis ,Meningococcal Infections

Liens